Flu Vaccine Rate Expected to Reach All-Time High for 2020-2021 Season
FRIDAY, March 19, 2021 -- Two-thirds of U.S. adults have received or intend to receive an influenza vaccination this flu season, according to a survey released by the University of Georgia (UGA).
Glen Nowak, director of the UGA Center for Health and Risk Communication in Athens, and colleagues conducted a survey of 1,027 U.S. adults in December 2020.
According to the results of the survey, 43.5 percent of respondents reported having already received a flu vaccination, with an additional 13.5 percent stating they "definitely will get one" and 9.3 percent stating they "probably will get one." This increase in vaccination, which was only 48.4 percent in 2019-2020, was driven by people 60 years and older, of whom 61.5 percent said they already received the influenza vaccine, 12 percent said they "would definitely get it," and 5.8 percent said they "would probably get it."
"These results strongly suggest the United States will be crossing an important threshold this flu season, which is over half of U.S. adults getting a flu vaccination," Nowak said in a statement.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
WEDNESDAY, April 21, 2021 -- Improper disinfection and not following contamination prevention protocols are among the nine violations found by U.S. Food and Drug Administration...
WEDNESDAY, April 21, 2021 -- Since the first COVID-19 vaccine was approved in December, millions of Americans have eagerly sought to find and receive one. But a new report reveals...
WEDNESDAY, April 21, 2021 -- A pathogenic platelet factor 4 (PF4)-dependent syndrome has been observed rarely after administration of the ChAdOx1 nCoV-19 vaccine, according to a...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.